|
|
Article: Genset obtains United States patent.(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- February 1, 2002
CopyrightCOPYRIGHT 2002 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Genset (France) has patented PG1, a gene associated with prostate cancer. The invention provides polynucleotides including biallelic markers derived from PG1 and from flanking genomic regions. Primers hybridizing to these biallelic markers and regions flanking are also provided. This invention provides polynucleotides and methods suitable for genotyping a nucleic acid containing sample for one or more biallelic markers of the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Patent No. 07601739 Issued on Oct. 13, Assigned to Virgina ...
US Fed News Service, Including US State News;
October 15, 2009 ;
422 words
... ... properties for treatment of prostate cancer and androgen receptor dependent ... provided. In particular, the invention provides compounds that are tetrahydroquinoline ... the treatment of breast and prostate cancer, and osteoporosis. The original ...
|
|